Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
about
Further studies on the prevalence of isolated sleep paralysis in black subjectsAdverse Psychiatric Effects Associated with Herbal Weight-Loss ProductsPharmacological treatment of anxiety disorders: current treatments and future directionsAn animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamusFear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflexSerotonin function in anxietyThe age of anxiety: role of animal models of anxiolytic action in drug discovery.Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxietyIncreased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder.Models and mechanisms of anxiety: evidence from startle studies.Auditory evoked potentials in panic disorder.The modification of breathing behavior. Pavlovian and operant control in emotion and cognition.Elevated plasma levels of neuropeptide Y in female fibromyalgia patients.Melatonin responses to clonidine and yohimbine challengesCognitive impairment in acute cocaine withdrawal.Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers.Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder.Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers.Cognitive enhancers for anxiety disorders.Theoretical and therapeutic considerations for the anxiety disorders.Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendritesChronic corticosterone exposure during adolescence reduces impulsive action but increases impulsive choice and sensitivity to yohimbine in male Sprague-Dawley rats.Structural and functional models of depression: from sub-types to substrates.Evaluation of psychopathology in patients with paroxysmal supraventricular tachycardia.Management of panic disorders.The acute effects of the thermogenic supplement Meltdown on energy expenditure, fat oxidation, and hemodynamic responses in young, healthy males.Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder.Effects of yohimbine and hydrocortisone on panic symptoms, autonomic responses, and attention to threat in healthy adults.Serotonin selectivity for obsessive compulsive and panic disordersGenetic Polymorphism of 1019C/G (rs6295) Promoter of Serotonin 1A Receptor and Catechol-O-Methyltransferase in Panic Disorder.A review of the psychopharmacology of panic disorder: individual differences and non specific factors.The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies.New ways of treating panic disorder.Alcoholism and panic disorder: is the comorbidity more than coincidence?Serotonin function and human anxiety disorders.Dissociable effects of cocaine and yohimbine on impulsive action and relapse to cocaine seeking.Stress, norepinephrine and depression.A biopsychosocial understanding of the irritable bowel syndrome: a review.Panic disorder in university students: a review.Differential effects of the pharmacological stressor yohimbine on impulsive decision making and response inhibition.
P2860
Q24649350-F1A58E43-BBA2-4C93-B395-12F89B2A2AA7Q26784276-A6DA009A-45B4-4B46-B2EA-543F3D8322B5Q26851461-D9F0E0A0-5973-4BAA-814F-27DBE6FC8066Q27008085-3A1A0A46-CC9D-4146-B091-B5A9F4FCC72CQ28307461-4B73533F-DF6A-42DF-85A3-F072341E4C54Q30051329-0B9C937A-1B64-454A-8976-388DDA624D42Q30462832-89C9D384-8AEC-4CFB-B072-155F4A24CD8EQ30477934-4C242B14-2A3F-45C3-82B5-5C9B81212EA4Q30480711-9858ECCE-884C-466E-B851-F3CE23230585Q30488271-C982095E-92CD-4B67-BCC7-E85517660C4BQ30499001-AD4072B6-5419-47D2-B42A-6A02DD8B7139Q33723022-A25EE53D-E601-4319-8B45-EF4FF297F3A5Q33892112-3BE23FFE-1CAC-44D7-9BAA-35743F2303F4Q33921604-F6D4E9B7-A81C-4332-B48A-B86FDDC38ABDQ34049459-3D4F6B5A-5B17-4E2A-9FF5-8BDA8C273088Q34298010-454F1E7C-C60B-4A79-ADE3-6E04C9D62797Q34299358-063580B0-1279-4E1A-A55D-5EF227F61683Q34502908-4F923219-2A8F-4102-BDFF-AC1B8B308E45Q35043125-AFED8CC8-DA26-43CE-8CE1-C67067FF6543Q35274922-2D675CB5-457F-4349-A70C-55BEA574E255Q35846750-320F2F56-9A38-4916-80D7-83094C086E58Q35982239-83F449C1-E883-4472-A1AF-BB47157B4E73Q36018497-B1278B55-6B8B-4E96-A3A6-A8D678364E88Q36608464-AC380855-3462-41E4-8FC8-53A0DDCC6273Q37042373-E24E84F0-A3B6-40F3-8E5F-8B86216B68EFQ37088450-0B1A46CF-F34F-4FD0-AE2E-2AF8B9F7A798Q37159913-7DBD686C-8E70-4A00-84F2-F12EBCFAE5FEQ37340123-4F7EFE5D-6F6E-4B16-8C75-04221EBB77EDQ37423109-52C356C1-107B-4EBF-BC40-531CC7ACAEDDQ37589448-0EEEB03F-FB03-42C9-A879-8239B1018F3CQ37741811-1ED845A3-A88E-4C07-825E-23271F0F8271Q37763406-4607E07F-7EC6-4002-9534-65C2498D03C2Q37779052-433F407E-41C8-4890-8ABD-803B0FBEC7F0Q37915749-3121FFC2-E80B-4F40-B202-D94FDC7B368CQ38004479-FD9B8D64-A6E6-409E-9D47-E8EA1D023B8DQ38601223-1A6CB450-5E0B-4F2C-AB25-93127692A39DQ38777577-D37B2B86-A950-4A67-AA43-B6B4F53979DFQ39452688-88DAB3AE-08CC-40B9-A4E1-96AE6C81C6CEQ39686530-FF2416A5-B3F3-44E6-8D16-48868F71A976Q39717506-195514D8-A069-4BD0-BF7C-937E4EBBBEE6
P2860
Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Noradrenergic function in pani ...... goraphobia and panic disorder.
@en
type
label
Noradrenergic function in pani ...... goraphobia and panic disorder.
@en
prefLabel
Noradrenergic function in pani ...... goraphobia and panic disorder.
@en
P2093
P1433
P1476
Noradrenergic function in pani ...... goraphobia and panic disorder.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1984.01790190025003
P407
P577
1984-08-01T00:00:00Z